A rheumatoid factor paradox: inhibition of rituximab effector function. - Wikidata - wikimedia - TriplyDB

A rheumatoid factor paradox: inhibition of rituximab effector function.

A rheumatoid factor paradox: inhibition of rituximab effector function.

http://www.wikidata.org/entity/Q30418884

about

Possible implication of Fc γ receptor-mediated trogocytosis in susceptibility to systemic autoimmune disease Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity.Rheumatoid factors: clinical applications.Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.Evading pre-existing anti-hinge antibody binding by hinge engineering.Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity.

P2860

Q34656459-E7BAB5CF-C2AB-45CA-8D0D-1764959AFE10 Q36214720-87BD3782-31F8-4206-B6E7-DAB3BEBCA28A Q37353700-4FEC9B52-B718-4156-B754-E76208EFFD96 Q41104888-2E5A34F5-0A16-45B6-97F8-D6FCA59D1845 Q42027130-07ECF70B-7C06-49AE-B4DA-6D7AF452BAE1 Q46889515-57CE1E8C-8207-4FA4-95A9-3CC414F22E08 Q52361124-D26219C2-9A80-4091-8357-A303B0280D58

P2860

A rheumatoid factor paradox: inhibition of rituximab effector function.

http://www.wikidata.org/entity/Q30418884

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A rheumatoid factor paradox: inhibition of rituximab effector function.

@ast

A rheumatoid factor paradox: inhibition of rituximab effector function.

@en

type

label

A rheumatoid factor paradox: inhibition of rituximab effector function.

@ast

A rheumatoid factor paradox: inhibition of rituximab effector function.

@en

prefLabel

A rheumatoid factor paradox: inhibition of rituximab effector function.

@ast

A rheumatoid factor paradox: inhibition of rituximab effector function.

@en

P1433

Q30418884-5764B682-0216-4316-A7BD-51E93D915B32

P1476

Q30418884-02760C85-73B1-482F-8844-493EB7F1161C

P2093

Q30418884-18A1251C-70A4-4501-A687-6CAF8D71D1BE

Q30418884-6E4B6338-879E-4F59-B518-66239BE561EB

Q30418884-76020D2C-166A-414A-B2A9-CFDB739E4BD6

Q30418884-D4A3D9B9-6E76-4A85-9052-941250385F38

P2860

Q30418884-04E7453A-5D62-4AEE-8CF8-938C88923076

Q30418884-0D0F7041-376E-4FBA-BCC1-5ED292F1A3B3

Q30418884-162E9D49-3429-406E-B92A-ED85DA54DDB6

Q30418884-17366E47-92AE-49D0-97D5-79AF9752CAD7

Q30418884-1F241584-4358-4DCB-8841-18E058CACCAD

Q30418884-22F9C84B-48E9-486B-BC58-5BD979BC5C94

Q30418884-267AE0A1-34D6-4A63-9ABE-6C2C0A061A54

Q30418884-2FF9408E-0F99-485C-920C-BA6FC2F1777F

Q30418884-3000207E-46FF-4504-9DE2-12835B9A996C

Q30418884-43DE13E7-0E17-4A8D-B5B2-AA5D9752CCA0

P2888

Q30418884-481A3A34-4CA5-47AA-A239-47CAFB10572F

P304

Q30418884-FD51EF0E-B227-4AC9-B1A9-2EBEF04D3CE3

P31

Q30418884-4D8B1A13-B905-4E39-9AFF-7CD044DE0FDB

P356

Q30418884-BA760C47-402F-4386-8D00-6E2988B402AB

P433

Q30418884-70FE8FDB-131F-40AD-A04D-5BE08B929795

P478

Q30418884-0289E442-5FC7-46BA-B206-F467EBADDECF

P577

Q30418884-8458093C-E4CC-4478-A551-1DA5AC01CD0F

P5875

Q30418884-C16145F6-8AD2-4BAD-94A3-2B2A566623A9

P6179

Q30418884-3EC42429-9C48-41C8-BA26-3A0D7E40CF1C

P698

Q30418884-E4205AFF-386E-411B-BF6C-B20304E47580

P932

Q30418884-A48B0528-E32B-481D-A2AC-7D03CBC13B7C

P356

P1433

Arthritis Research and Therapy

P1476

A rheumatoid factor paradox: inhibition of rituximab effector function.

@en

P2093

Irene Shyu

http://www.w3.org/2001/XMLSchema#string

Jonathan D Jones

http://www.w3.org/2001/XMLSchema#string

Marianna M Newkirk

http://www.w3.org/2001/XMLSchema#string

William F C Rigby

http://www.w3.org/2001/XMLSchema#string

P2860

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

Crystal Structure of a Human Autoimmune Complex between IgM Rheumatoid Factor RF61 and IgG1 Fc Reveals a Novel Epitope and Evidence for Affinity Maturation

Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction

Complement. First of two parts

The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes.

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.

New roles for rheumatoid factor.

Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis.

Rheumatoid factors: host resistance or autoimmunity?

Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor

P2888

P304

R20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR4152

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235373544

http://www.w3.org/2001/XMLSchema#string

P6179

1017491256

http://www.w3.org/2001/XMLSchema#string

P698

23351360

http://www.w3.org/2001/XMLSchema#string

P932

3672827

http://www.w3.org/2001/XMLSchema#string